BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26462248)

  • 1. Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma Using Proteomic and Transcriptomic Data.
    Kaddi CD; Wang MD
    IEEE J Biomed Health Inform; 2017 Jan; 21(1):246-253. PubMed ID: 26462248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models for predicting stage in head and neck squamous cell carcinoma using proteomic data.
    Kaddi CD; Wang MD
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5216-9. PubMed ID: 25571169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-coding landscape of head and neck squamous cell carcinoma.
    Zou AE; Zheng H; Saad MA; Rahimy M; Ku J; Kuo SZ; Honda TK; Wang-Rodriguez J; Xuan Y; Korrapati A; Yu V; Singh P; Grandis JR; King CC; Lippman SM; Wang XQ; Hinton A; Ongkeko WM
    Oncotarget; 2016 Aug; 7(32):51211-51222. PubMed ID: 27323410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display.
    Carles A; Millon R; Cromer A; Ganguli G; Lemaire F; Young J; Wasylyk C; Muller D; Schultz I; Rabouel Y; Dembélé D; Zhao C; Marchal P; Ducray C; Bracco L; Abecassis J; Poch O; Wasylyk B
    Oncogene; 2006 Mar; 25(12):1821-31. PubMed ID: 16261155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
    de Lena PG; Paz-Gallardo A; Paramio JM; García-Escudero R
    Clin Epigenetics; 2017; 9():36. PubMed ID: 28405244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
    Shen S; Bai J; Wei Y; Wang G; Li Q; Zhang R; Duan W; Yang S; Du M; Zhao Y; Christiani DC; Chen F
    Oncol Rep; 2017 Dec; 38(6):3403-3411. PubMed ID: 29130107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma.
    Braakhuis BJ; Graveland AP; Dijk F; Ylstra B; van Wieringen WN; Leemans CR; Brakenhoff RH
    Oral Dis; 2013 Jul; 19(5):452-5. PubMed ID: 23034102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting miRNA targets for head and neck squamous cell carcinoma using an ensemble method.
    Gao H; Jin H; Li G
    Int J Biol Markers; 2018 Jan; 33(1):87-93. PubMed ID: 28665450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene expression analyses and their possible clinical benefit in head and neck cancer].
    Dietz A; Loeffler M; Rosolowski M; Kreuz M; Lordick F; Knödler M; Mozet C; Wichmann G
    HNO; 2015 Nov; 63(11):773-85. PubMed ID: 26471186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
    Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.